Back to search

National and Kapodistrian University of Athens

Γενετικός έλεγχος ασθενών με σύνδρομο μακρού QT και σύνδρομο Brugada

Abstract

dc:description

Long QT syndrome (LQTS) and Brugada syndrome (BrS) are inherited cardiac arrhythmias that may lead to sudden death in patients with structurally normal heart and are characterized by variable penetrance and expressivity. Mutations in the genes of the major cardiac K+ and Na+ channels are responsible for LQTS in 70% of cases, while mutations of the Na+ cardiac channel gene are responsible for BrS in 20% of cases. The genetic basis of these syndromes in the Greek population has not been previously explored. We developed a uniform and efficient methodology for genetic testing of the major cardiac ion channel genes my means of PCR-SSCP analysis and DNA sequencing that was applied to patients with LQTS and BrS. In particular, we genetically screened 18 patients with a high, intermediate and low probability of LQTS and 15 patients with definite or borderline diagnosis of BrS, based on clinical criteria. Genetic testing was positive in 78% of patients with a high probability for LQTS and in 43% of patients with a definite diagnosis of BrS. In LQTS, the majority of detected mutations have been previously described and all belonged to types LQT1 and LQT2 of the syndrome, while in BrS all detected mutations were novel. In addition, 28 single nucleotide polymorphisms were detected, 6 of which are novel. Existing genotype-phenotype correlations were successfully used to predict the genetic type in one case and were thereafter found efficiently predictive of the genetic test results of the rest of the patients. After the completion of genetic analysis of the probands, all family relatives that consented were genetically screened. LQTS cascade family screening revealed 12 carriers among 17 relatives, 5 of which did not fulfill the criteria for a clinical diagnosis. BrS cascade family screening revealed 7 carriers among 14 relatives, 5 of which did not fulfill the criteria for a clinical diagnosis. All LQTS probands and relative carriers received β blocker treatment and have remained completely asymptomatic in 1-5 years follow-up. Our results are in accordance with international data that genetic testing of the major ion channel genes is efficient in genotyping the majority of LQTS patients with a strong clinical diagnosis, while in BrS, genotyping efficiency was found higher than expected. In total, the Greek genetic pool was found to differentiate, without significant diversions. Genetic testing is a strong diagnostic tool for revealing subclinical and silent forms of the syndromes in probands’ families, while identification of carrier status may contribute substantially in patient management in terms of constant follow-up, risk stratification and prophylactic measures and treatment.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Κόττα, Χριστίνα-Μαρία
  • Kotta, Maria-Christina

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/28553

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Κόττα, Χριστίνα-Μαρία; Kotta, Maria-Christina. Γενετικός έλεγχος ασθενών με σύνδρομο μακρού QT και σύνδρομο Brugada. National and Kapodistrian University of Athens, 2009. http://hdl.handle.net/10442/hedi/28553